No Data
No Data
Wisdom Hong Kong Stock Investment Journal | August 27th
HK Stock Investment Log | August 27, 2024
CMB International Capital Corp Starts Hansoh Pharmaceutical Group at Buy With HK$22.06 Price Target
Hong Kong stocks surge | Hansoh Pharma (03692) rises more than 4% in the afternoon. The company has successfully transformed into an innovative drug company. Generic drugs will contribute stable cash flow to the company.
Hansoh Pharma (03692) rose over 4% in the afternoon, as of the time of publication, up 4.29%, trading at 17.98 Hong Kong dollars, with a turnover of 48.9651 million Hong Kong dollars.
ZhaoYin International: First give hansoh pharma (03692) a "buy" rating and a target price of HKD 22.06.
ZhaoYin International expects that the total revenue of Hansoh Pharma (03692) will increase by 19% year-on-year to reach 12 billion RMB in 2024.
If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Hansoh Pharma's Cancer Drug Fast-Tracked by FDA
No Data